Symptoms
Recognising symptoms early is critical for reducing the risk of intravascular haemolysis (IVH), thrombosis and organ damage.1
Learn More
Adverse Event Reporting

Please report any adverse events via your national reporting system. Adverse events can also be reported to Alexion, AstraZeneca Rare Disease by contacting: https://contactazmedical.astrazeneca.com/
Kulasekararaj AG, et al. The Importance of Terminal Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria. Therapeutic Advances in Hematology. 2022;13:20406207221091046. Sharma VR. Paroxysmal Nocturnal Hemoglobinuria: Pathogenesis, Testing, and Diagnosis. Clinical Advances in Hematology & Oncology. 2013 1-12. Nishimura J-I, et al. Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan. Medicine (Baltimore). 2004;83:193–207.  Schrezenmeier H, et al. Baseline Characteristics and Disease Burden in Patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014;99:922–929. Lee JW, et al. Avulizumab (ALXN1210) vs Eculizumab in Adult Patients with PNH Naive to Complement Inhibitors: the 301 Study. Blood. 2019;133(6):530–539. Hill A, et al. Effect of Eculizumab on Haemolysis-Associated Nitric Oxide Depletion, Dyspnoea, and Measures of Pulmonary Hypertension in Patients with Paroxysmal Nocturnal Haemoglobinuria. British Journal of Haematology. 2010;149(3):414–425. Hillmen P, et al. Long-term effect of the Complement Inhibitor Eculizumab on Kidney Function in Patients with Paroxysmal Nocturnal Hemoglobinuria. American Journal of Hematology. 2010;85:553–559. Schrezenmeier H, et al. Baseline Clinical Characteristics and Disease Burden in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis from the International PNH Registry. Annals of Hematology. 2020;99(7):1505–1514. Jang JH, et al. Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry. Journal of Korean Medical Science. 2016;31(2):214–221. de Latour RP, et al. Paroxysmal Nocturnal Hemoglobinuria: Natural History of Disease Subcategories. Blood. 2008;112:3099–3106. Kokoris S L, et al. Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment. Hematology. 2018 8):558-566. Hill A.Paroxysmal nocturnal haemoglobinuria. Nature Reviews Disease Primers 2017. Hillmen P, et al. Effect of the Complement Inhibitor Eculizumab on Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 2007;110(12):4123–4128.  advance I am a healthcare professional registered in the EU I am not a
healthcare professional